LLYELI LILLY & CoMega cap · $1.11T · FY ending 2025-12-31
$1181.87-0.56% · 2026-07-13 · EOD
61/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality78
margins & F-ScoreValue28
P/E 51.5 · 91% of 12-mo rangeMomentum66
golden · price above 200-daySmart Money72
buying · 1 funds · 0P/2S insidersBullish stackGolden crossAbove 200-day
vs S&P 500+0.3%
6-mo excess Trailing performance1M +4.0%
3M +25.8%
6M +8.9%
YTD +9.4%
1Y +49.5%
P/E vs its last 12 months (our price history): 27.3 low → 53.8 high
Current price sits at the 91th percentile of that window — near the top (richer). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Piotroski F5/9
fundamental strength ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 20%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio26.1%
comfortable Shareholder yield0.9%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net buying0P / 2S insiders · 1 funds hold · 2 Congress buys
Recent insidersYuffa Ilya · EVP&Pres, LLY USA&Global CapabSELL$2.9M
LILLY ENDOWMENT INC · InsiderSELL$15.8M
Fund holders (13F)Fisher Asset Management (Ken Fisher)$4.45B1.5% of book
CongressRohit KhannaBUY2026-06-02
Gilbert CisnerosBUY2026-06-10
Bhealth · 78/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.